Valvular & structural heart diseaseCohort study

Residual left atrial v wave predicts clinical outcome of transcatheter edge-to-edge mitral valve repair

ESC Heart FailPublished

  • prospective observational study

Authors' conclusion

High residual LAvP predicts death or hospitalization for heart failure after M-TEER. LAvP after device implantation provides incremental prognostic information beyond echocardiographic MR grading and may therefore assist intraprocedural decision-making during M-TEER.

Study context

Population
Patients undergoing M-TEER for primary or secondary mitral regurgitation (MR)patients undergoing M-TEER
Participants
299 patients
Exposure
Intraprocedural left atrial (LA) pressure as predictor of clinical outcome
Outcome
Death or hospitalization for heart failure
Follow-up
2-year follow-up

Main finding

As reported in the abstract

LAvP post M-TEERHazard ratio per 10 mmHg (CI)P value
univariate analysis
1.37(1.15–1.63)
P < 0.001
multivariate analysis, independent of echocardiographic MR severity
1.29(1.06–1.57)
P = 0.012

Observational data: associations, not effects.

Further findings

Baseline characteristics

Mean age
76.6 ± 8.2 years
Secondary mitral regurgitation
62.9%

Reduction to MR grade I or II

Reduction to MR grade I or II achieved
95.3%

LAvP before vs after device implantation

LAvP decreased from
30.5 ± 15.0 to 23.2 ± 10.4 mmHg (P < .001)

LAmP before vs after device implantation

modest reduction of LAmP from
16.6 ± 6.3 to 15.3 ± 5.9 mmHg (P = .006)

Original publication

Residual left atrial v wave predicts clinical outcome of transcatheter edge-to-edge mitral valve repair. ESC Heart Fail. Published 23 March 2026. doi:10.1093/eschf/xvag086

Summarised from the published abstract; every number is checked against it